Jentzsch M, Grimm J, Bill M, Brauer D, et al. Clinical value of the measurable residual disease status within the ELN2017 risk groups in AML patients undergoing allogeneic stem cell transplantation. Am J Hematol 2021;96:E237-E239.
PMID: 33811773